Albumin 20% GCC 50 ml.
Restoration and maintainance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropiate.
Restoration and maintainance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropiate.
Treatment and prophylaxis of bleeding in patients with haemophilia A
Treatment and prophylaxis of bleeding in patients with haemophilia A
1. Hypogammaglobulinemia
2. Idiopathic Thrombocytopenic Purpura (ITP)
3. Guillain-Barre Syndrome
4. Kawasaki Syndrome
1. Hypogammaglobulinemia
2. Idiopathic Thrombocytopenic Purpura (ITP)
3. Guillain-Barre Syndrome
4. Kawasaki Syndrome
Replacement therapy in:
a) Primary immunodeficiency syndromes
b) Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
c) Children with congenital AIDS and recurrent infections
Immunomodulation
a) Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count
b) Guillain Barré syndrome
c) Kawasaki disease
Allogeneic bone marrow transplantation
Replacement therapy in:
a) Primary immunodeficiency syndromes
b) Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
c) Children with congenital AIDS and recurrent infections
Immunomodulation
a) Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count
b) Guillain Barré syndrome
c) Kawasaki disease
Allogeneic bone marrow transplantation
Adjuvant therapy of severe bacterial infections additional to antibiotic therapy.
Immunoglobulin substitution in immunocompromized patients.
Adjuvant therapy of severe bacterial infections additional to antibiotic therapy.
Immunoglobulin substitution in immunocompromized patients.